Opis działalności
PharmaSGP is a pure-play consumer health company with a broad portfolio of leading chemical-free non-prescription pharmaceuticals sold over the counter (“OTC”) and other healthcare products. PharmaSGP’s products are sold exclusively through pharmacies. Its products are based on natural active pharmaceutical ingredients with documented efficacy and fewer known side effects than most chemical-based pharmaceuticals. The Company’s core brands cover chronic indications, including pain and other age-related ailments.
Zarząd & Rada nadzorcza
| CEO |
| Natalie Weigand |
| Zarząd |
| Michael Rudolf, Peter Gerckens |
| Rada nadzorcza |
| Dr. Clemens Fischer, Madlena Hohlefelder, Dr. Axel Rebien |
Dane firmy
| Nazwa: |
PharmaSGP Holding SE |
| Adres: |
Lochhamer Schlag 21,D-82166 Gräfelfing |
| Telefon: |
+49-611-2058-5528 |
| Fax: |
+49-611-2058-5566 |
| E-mail: |
info@pharmasgp.com
|
| Internet: |
https://pharmasgp.com/ |
| Przemysł: |
Służba zdrowia |
| Sektor: |
Przemysł Farmaceutyczny |
| Podsektor: |
Przemysł Farmaceutyczny |
| Koniec roku finansowego: |
31.12 |
| Free float: |
- |
| Data IPO: |
19.06.2020 |
Relacje inwestorskie
| Nazwa: |
Claudius Krause |
| Telefon: |
+49-611-2058-5535 |
| Fax: |
- |
| E-mail: |
ir@pharmasgp.com
|
